Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05034835
Other study ID # 2020-A00657-32
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 12, 2021
Est. completion date January 2025

Study information

Verified date October 2021
Source Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape
Contact Vincent Detaille, Doctor
Phone 02 97 82 60 28
Email vincent.detaille@vyv3.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim is to study another alternative for the treatment of pain in people with CRPS. Indeed, the TRAB / Medullary occupational therapy department of the CMRRF in Kerpape used compression garments to reduce edema when it was present.In the case of CRPS of the upper limbs, gloves or compression sleeves are used to decrease the edema which is sometimes associated, although they are not supported for this indication. In this context, our clinical experience leads us to believe that there would also be some efficacy in neuropathic pain, this improvement being regularly described by patients.This study is expected to show a notable reduction in neuropathic pain thanks to the wearing of a compression garment.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date January 2025
Est. primary completion date October 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with CRPS of the upper limb with neuropathic pain - Diagnosis of CRPS according to the Budapest criteria - Diagnosis of neuropathic pain according to DN4 - CRPS evolving for more than 3 months - No phlebitis or open sores on the upper limbs - Patient consent to participate in the study - No modification of his drug treatment for 1 month - Affiliation to a social security scheme or beneficiary of such a scheme Exclusion Criteria: - Patient under guardianship, curatorship or safeguard of justice - Psychiatric pathology altering the ability to consent - Severe cognitive disorders that do not allow the patient to assess his pain - Skin pathology preventing the wearing of the compression garment - Patient who has previously worn a compression garment - History of vascular disorders of the upper limbs, lymph node dissection, or any other pathology that can lead to edema regardless of CRPS - Known allergy to one of the components of the compression garments of the Cerecare brand - Declared pregnancy, breastfeeding woman or woman of childbearing potential without contraception - Inability to put on the compression garment alone

Study Design


Intervention

Device:
usual treatment with compression garments (CERECARE)
For 3 months, the pain will be assessed every week, tolerance and compliance with compression garments will also be monitored. Participants will be reviewed specifically at a follow-up consultation for the 6-month and 1-year study. Various assessments will be carried out during these visits : assessment of pain, range of motion, muscle strength, sensitivity test, assessment of anxiety, depression and even quality of life.
Other:
usual treatment without compression garments (CERECARE)
For 3 months, the pain will be assessed every week, tolerance and compliance with compression garments will also be monitored. Participants will be reviewed specifically at a follow-up consultation for the 6-month and 1-year study. Various assessments will be carried out during these visits : assessment of pain, range of motion, muscle strength, sensitivity test, assessment of anxiety, depression and even quality of life.

Locations

Country Name City State
France CMRRF de Kerpape Ploemeur Bretagne

Sponsors (4)

Lead Sponsor Collaborator
Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape Clinique Mutualiste Lorient, Fondation Rothschild Paris, Groupement des Hôpitaux de l'Institut Catholique de Lille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The evolution of pain through Visual Analog Scale (VAS), measured every week for 3 months in the last 24 hours and in the last 7 days The VAS is a self-rated scale. It comes in the form of a 10 cm plastic ruler graduated in mm. On the face presented to the patient is a cursor which he moves along a straight line, one end of which corresponds to "No pain" and the other to "Maximum pain imaginable". The patient should, along this line, position the cursor where the pain is best located. On the other side, there are millimeter graduations seen only by the caregiver. The position of the cursor mobilized by the patient makes it possible to read the intensity of the pain, which is measured in mm. up to 3 months
Secondary Visual Analog Scale (VAS) The VAS is a self-rated scale. It comes in the form of a 10 cm plastic ruler graduated in mm. On the face presented to the patient is a cursor which he moves along a straight line, one end of which corresponds to "No pain" and the other to "Maximum pain imaginable". The patient should, along this line, position the cursor where the pain is best located. On the other side, there are millimeter graduations seen only by the caregiver. The position of the cursor mobilized by the patient makes it possible to read the intensity of the pain, which is measured in mm. At 6 months
Secondary Visual Analog Scale (VAS) The VAS is a self-rated scale. It comes in the form of a 10 cm plastic ruler graduated in mm. On the face presented to the patient is a cursor which he moves along a straight line, one end of which corresponds to "No pain" and the other to "Maximum pain imaginable". The patient should, along this line, position the cursor where the pain is best located. On the other side, there are millimeter graduations seen only by the caregiver. The position of the cursor mobilized by the patient makes it possible to read the intensity of the pain, which is measured in mm. At 1 year
Secondary Neuropathic Pain Symptom Inventory (NPSI) It's a tool developed and validated in French, composed of 12 items. It provides an overall score and 5 sub-scores Day 0
Secondary Neuropathic Pain Symptom Inventory (NPSI) It's a tool developed and validated in French, composed of 12 items. It provides an overall score and 5 sub-scores At 1,5 months
Secondary Neuropathic Pain Symptom Inventory (NPSI) It's a tool developed and validated in French, composed of 12 items. It provides an overall score and 5 sub-scores At 3 months
Secondary Neuropathic Pain Symptom Inventory (NPSI) It's a tool developed and validated in French, composed of 12 items. It provides an overall score and 5 sub-scores At 6 months
Secondary Neuropathic Pain Symptom Inventory (NPSI) It's a tool developed and validated in French, composed of 12 items. It provides an overall score and 5 sub-scores At 1 year
Secondary Modification of analgesic drug treatment The increase or decrease in doses between each visit will be collected by the doctor. He can rely on the booklet filled out by the patient. Day 0
Secondary Modification of analgesic drug treatment The increase or decrease in doses between each visit will be collected by the doctor. He can rely on the booklet filled out by the patient. At 1,5 months
Secondary Modification of analgesic drug treatment The increase or decrease in doses between each visit will be collected by the doctor. He can rely on the booklet filled out by the patient. At 3 months
Secondary Modification of analgesic drug treatment The increase or decrease in doses between each visit will be collected by the doctor. He can rely on the booklet filled out by the patient. At 6 months
Secondary Modification of analgesic drug treatment The increase or decrease in doses between each visit will be collected by the doctor. He can rely on the booklet filled out by the patient. At 1 year
Secondary Measurement of range of motion The range of motion is measured exploratory at different levels, for both sides:
Wrist range of motion, measured using posture foam and goniometer. This measures the amplitude in flexion, extension, radial tilt, ulnar tilt, and pronation and supination, both passively and actively.
Pulp-palm and pulp palmar fold distances of the fingers, measured using wedges of different lengths. One measurement is made per finger
Kapandji score, which is a score out of 10 based on achievable opposition for the thumb. 0 being the lowest score and 10 a normal score.
Day 0
Secondary Measurement of range of motion The range of motion is measured exploratory at different levels, for both sides:
Wrist range of motion, measured using posture foam and goniometer. This measures the amplitude in flexion, extension, radial tilt, ulnar tilt, and pronation and supination, both passively and actively.
Pulp-palm and pulp palmar fold distances of the fingers, measured using wedges of different lengths. One measurement is made per finger
Kapandji score, which is a score out of 10 based on achievable opposition for the thumb. 0 being the lowest score and 10 a normal score.
At 1,5 months
Secondary Measurement of range of motion The range of motion is measured exploratory at different levels, for both sides:
Wrist range of motion, measured using posture foam and goniometer. This measures the amplitude in flexion, extension, radial tilt, ulnar tilt, and pronation and supination, both passively and actively.
Pulp-palm and pulp palmar fold distances of the fingers, measured using wedges of different lengths. One measurement is made per finger
Kapandji score, which is a score out of 10 based on achievable opposition for the thumb. 0 being the lowest score and 10 a normal score.
At 3 months
Secondary Measurement of range of motion The range of motion is measured exploratory at different levels, for both sides:
Wrist range of motion, measured using posture foam and goniometer. This measures the amplitude in flexion, extension, radial tilt, ulnar tilt, and pronation and supination, both passively and actively.
Pulp-palm and pulp palmar fold distances of the fingers, measured using wedges of different lengths. One measurement is made per finger
Kapandji score, which is a score out of 10 based on achievable opposition for the thumb. 0 being the lowest score and 10 a normal score.
At 6 months
Secondary Measurement of range of motion The range of motion is measured exploratory at different levels, for both sides:
Wrist range of motion, measured using posture foam and goniometer. This measures the amplitude in flexion, extension, radial tilt, ulnar tilt, and pronation and supination, both passively and actively.
Pulp-palm and pulp palmar fold distances of the fingers, measured using wedges of different lengths. One measurement is made per finger
Kapandji score, which is a score out of 10 based on achievable opposition for the thumb. 0 being the lowest score and 10 a normal score.
At 1 year
Secondary Measurement of muscle strength in both hands the JAMAR® hydraulic hand dynamometer: measurement of the gripping force in kilograms
the PINCH® hydraulic pinch gauge: measures the pinch force in kilograms
Day 0
Secondary Measurement of muscle strength in both hands the JAMAR® hydraulic hand dynamometer: measurement of the gripping force in kilograms
the PINCH® hydraulic pinch gauge: measures the pinch force in kilograms
At 1,5 months
Secondary Measurement of muscle strength in both hands the JAMAR® hydraulic hand dynamometer: measurement of the gripping force in kilograms
the PINCH® hydraulic pinch gauge: measures the pinch force in kilograms
At 3 months
Secondary Measurement of muscle strength in both hands the JAMAR® hydraulic hand dynamometer: measurement of the gripping force in kilograms
the PINCH® hydraulic pinch gauge: measures the pinch force in kilograms
At 6 months
Secondary Measurement of muscle strength in both hands the JAMAR® hydraulic hand dynamometer: measurement of the gripping force in kilograms
the PINCH® hydraulic pinch gauge: measures the pinch force in kilograms
At 1 year
Secondary Measurement of hand circumference The circumference of the hand is measured in different places. A total of 15 measurements are taken. Both hands are measured.
The analysis will be based on the difference of the sum of the 15 measures for each of the hands.
Day 0
Secondary Measurement of hand circumference The circumference of the hand is measured in different places. A total of 15 measurements are taken. Both hands are measured.
The analysis will be based on the difference of the sum of the 15 measures for each of the hands.
At 1,5 months
Secondary Measurement of hand circumference The circumference of the hand is measured in different places. A total of 15 measurements are taken. Both hands are measured.
The analysis will be based on the difference of the sum of the 15 measures for each of the hands.
At 3 months
Secondary Measurement of hand circumference The circumference of the hand is measured in different places. A total of 15 measurements are taken. Both hands are measured.
The analysis will be based on the difference of the sum of the 15 measures for each of the hands.
At 6 months
Secondary Measurement of hand circumference The circumference of the hand is measured in different places. A total of 15 measurements are taken. Both hands are measured.
The analysis will be based on the difference of the sum of the 15 measures for each of the hands.
At 1 year
Secondary Saint-Antoine Pain Questionnaire (QDSA) Illustrating the different components of pain, the QDSA (French version of the Mac Gill Pain Questionnary-MPQ) essentially allows a qualitative assessment of chronic pain, in particular neuropathic pain. It is a questionnaire of 58 qualifying words divided into subclasses: sensory pain on the one hand, affective and emotional pain on the other. The patient is asked to select the adjectives corresponding to his pain and then to note them from 0 (absent) to 4 (very strong). This self-assessment scale makes it possible in clinical practice to specify the involvement of the sensory and the emotional in pain intensity. Day 0
Secondary Saint-Antoine Pain Questionnaire (QDSA) Illustrating the different components of pain, the QDSA (French version of the Mac Gill Pain Questionnary-MPQ) essentially allows a qualitative assessment of chronic pain, in particular neuropathic pain. It is a questionnaire of 58 qualifying words divided into subclasses: sensory pain on the one hand, affective and emotional pain on the other. The patient is asked to select the adjectives corresponding to his pain and then to note them from 0 (absent) to 4 (very strong). This self-assessment scale makes it possible in clinical practice to specify the involvement of the sensory and the emotional in pain intensity. At 1,5 months
Secondary Saint-Antoine Pain Questionnaire (QDSA) Illustrating the different components of pain, the QDSA (French version of the Mac Gill Pain Questionnary-MPQ) essentially allows a qualitative assessment of chronic pain, in particular neuropathic pain. It is a questionnaire of 58 qualifying words divided into subclasses: sensory pain on the one hand, affective and emotional pain on the other. The patient is asked to select the adjectives corresponding to his pain and then to note them from 0 (absent) to 4 (very strong). This self-assessment scale makes it possible in clinical practice to specify the involvement of the sensory and the emotional in pain intensity. At 3 months
Secondary Saint-Antoine Pain Questionnaire (QDSA) Illustrating the different components of pain, the QDSA (French version of the Mac Gill Pain Questionnary-MPQ) essentially allows a qualitative assessment of chronic pain, in particular neuropathic pain. It is a questionnaire of 58 qualifying words divided into subclasses: sensory pain on the one hand, affective and emotional pain on the other. The patient is asked to select the adjectives corresponding to his pain and then to note them from 0 (absent) to 4 (very strong). This self-assessment scale makes it possible in clinical practice to specify the involvement of the sensory and the emotional in pain intensity. At 6 months
Secondary Saint-Antoine Pain Questionnaire (QDSA) Illustrating the different components of pain, the QDSA (French version of the Mac Gill Pain Questionnary-MPQ) essentially allows a qualitative assessment of chronic pain, in particular neuropathic pain. It is a questionnaire of 58 qualifying words divided into subclasses: sensory pain on the one hand, affective and emotional pain on the other. The patient is asked to select the adjectives corresponding to his pain and then to note them from 0 (absent) to 4 (very strong). This self-assessment scale makes it possible in clinical practice to specify the involvement of the sensory and the emotional in pain intensity. At 1 year
Secondary Cartographic assessment of pain The cartographic assessment of pain is carried out following the QDSA. Using schematic representations of the hand (dorsal face and palmar face for each hand), the patient locates and describes his pain. Day 0
Secondary Cartographic assessment of pain The cartographic assessment of pain is carried out following the QDSA. Using schematic representations of the hand (dorsal face and palmar face for each hand), the patient locates and describes his pain. At 1,5 months
Secondary Cartographic assessment of pain The cartographic assessment of pain is carried out following the QDSA. Using schematic representations of the hand (dorsal face and palmar face for each hand), the patient locates and describes his pain. At 3 months
Secondary Cartographic assessment of pain The cartographic assessment of pain is carried out following the QDSA. Using schematic representations of the hand (dorsal face and palmar face for each hand), the patient locates and describes his pain. At 6 months
Secondary Cartographic assessment of pain The cartographic assessment of pain is carried out following the QDSA. Using schematic representations of the hand (dorsal face and palmar face for each hand), the patient locates and describes his pain. At 1 year
Secondary Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire This is a subjective self-assessment questionnaire of the overall functional capacity of the two upper limbs, composed of 30 items, rated from 1 to 5 depending on the difficulty of the task described, leading to a score out of 100. Day 0
Secondary Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire This is a subjective self-assessment questionnaire of the overall functional capacity of the two upper limbs, composed of 30 items, rated from 1 to 5 depending on the difficulty of the task described, leading to a score out of 100. At 1,5 months
Secondary Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire This is a subjective self-assessment questionnaire of the overall functional capacity of the two upper limbs, composed of 30 items, rated from 1 to 5 depending on the difficulty of the task described, leading to a score out of 100. At 3 months
Secondary Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire This is a subjective self-assessment questionnaire of the overall functional capacity of the two upper limbs, composed of 30 items, rated from 1 to 5 depending on the difficulty of the task described, leading to a score out of 100. At 6 months
Secondary Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire This is a subjective self-assessment questionnaire of the overall functional capacity of the two upper limbs, composed of 30 items, rated from 1 to 5 depending on the difficulty of the task described, leading to a score out of 100. At 1 year
Secondary Hospital Anxiety and Depression (HAD) Scale It comprises 14 items, allowing the obtaining of 2 scores out of 21 points, corresponding to the dimensions of anxiety and depression Day 0
Secondary Hospital Anxiety and Depression (HAD) Scale It comprises 14 items, allowing the obtaining of 2 scores out of 21 points, corresponding to the dimensions of anxiety and depression At 1,5 months
Secondary Hospital Anxiety and Depression (HAD) Scale It comprises 14 items, allowing the obtaining of 2 scores out of 21 points, corresponding to the dimensions of anxiety and depression At 3 months
Secondary Hospital Anxiety and Depression (HAD) Scale It comprises 14 items, allowing the obtaining of 2 scores out of 21 points, corresponding to the dimensions of anxiety and depression At 6 months
Secondary Hospital Anxiety and Depression (HAD) Scale It comprises 14 items, allowing the obtaining of 2 scores out of 21 points, corresponding to the dimensions of anxiety and depression At 1 year
Secondary The Short Form (36) Health Survey This is a standardized test for measuring the quality of life. It includes 36 items divided into 8 dimensions (physical functioning, role limitations related to physical health, physical pain, general health, vitality [energy / fatigue], functioning or social well-being, role limitations related to mental health, Mental Health). Day 0
Secondary The Short Form (36) Health Survey This is a standardized test for measuring the quality of life. It includes 36 items divided into 8 dimensions (physical functioning, role limitations related to physical health, physical pain, general health, vitality [energy / fatigue], functioning or social well-being, role limitations related to mental health, Mental Health). At 1,5 months
Secondary The Short Form (36) Health Survey This is a standardized test for measuring the quality of life. It includes 36 items divided into 8 dimensions (physical functioning, role limitations related to physical health, physical pain, general health, vitality [energy / fatigue], functioning or social well-being, role limitations related to mental health, Mental Health). At 3 months
Secondary The Short Form (36) Health Survey This is a standardized test for measuring the quality of life. It includes 36 items divided into 8 dimensions (physical functioning, role limitations related to physical health, physical pain, general health, vitality [energy / fatigue], functioning or social well-being, role limitations related to mental health, Mental Health). At 6 months
Secondary The Short Form (36) Health Survey This is a standardized test for measuring the quality of life. It includes 36 items divided into 8 dimensions (physical functioning, role limitations related to physical health, physical pain, general health, vitality [energy / fatigue], functioning or social well-being, role limitations related to mental health, Mental Health). At 1 year
Secondary Observance of wearing the compression garment Compliance with the wearing of the compression garment will be measured by the average number of hours of wearing the garment per day, which will be evaluated on the patient's statements in the experimental arm during the visits. Every week for 3 months
Secondary Tolerance of wearing the compression garment The tolerance of wearing the compression garment will be assessed by recording the presence of irritation or surface skin lesion, compression felt as being too unpleasant or even unbearable by the patient in the experimental arm and leading to stopping wearing. Every week for 3 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04066933 - Forms of Cervical Brachial Syndrome Treated With Plasma Concentrate Enriched for A2M
Completed NCT04597866 - Treatment of Complex Regional Pain Syndrome, a Long-term Follow-up
Completed NCT04060875 - Research Protocol for Karuna Labs Inc.: Safety and Efficacy of Virtual Reality Graded Motor Imagery for Chronic Pain
Terminated NCT01954888 - Impact of the Ultrasound-guided Approach on the Efficiency and Safety of the Stellate Ganglion Block in Chronic Pain N/A
Terminated NCT00689585 - Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) Phase 2
Recruiting NCT00377468 - Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study) Phase 2
Recruiting NCT05787119 - Benefit of Augmented Reality Mirror Therapy in Addition to Conventional Management in Complex Regional Pain Syndrome of the Upper Extremity N/A
Recruiting NCT05523934 - Retrospective Analysis of capsaïcin Patch in Complex Regional Pain Syndrome
Recruiting NCT04732325 - Sensory Testing of Multiple Forms of Spinal Cord Stimulation for Pain N/A
Completed NCT03174249 - Exposure Therapy Combined With Cortical Interventions for CRPS-II N/A
Recruiting NCT06033456 - Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome N/A
Active, not recruiting NCT04144972 - Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain N/A
Completed NCT02490436 - Novel Treatment Option for Neuropathic Pain Phase 2
Withdrawn NCT03316066 - Comparison of Volumes of Local Anesthetics on the Efficiency and Safety of Stellate Ganglion Block for CRPS of the Arm N/A
Recruiting NCT05491499 - Assessing the Impact of Exercise Based Intensive Interdisciplinary Pain Treatment (IIPT) on Endogenous Pain Modulation in Youth With Chronic Pain Syndromes
Completed NCT03291197 - Tolerability of Suprascapular and Median Nerve Blocks for the Treatment of Shoulder-hand Syndrome Phase 4
Completed NCT05696587 - Physical and Psychological Changes in CRPS Patients Undergoing Multimodal Rehabilitation N/A
Recruiting NCT02957240 - Graded Motor Imagery for Women at Risk for Developing Type I CRPS Following Closed Treatment of Distal Radius Fractures N/A
Terminated NCT00891397 - Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study) N/A
Recruiting NCT06215079 - Investigation of the Efficacy of Transcranial Magnetic Stimulation in Patients Developing Complex Regional Pain Syndrome Type 1 in the Upper Extremity During the Subacute-Chronic Period After Ischemic Stroke N/A